drug

hatg

1 story · latest Oct 13, 2026

Follow hatg. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Novartis

Timeline

SAB Biotherapeutics gets FDA Fast Track for T1D therapy SAB-142

Oct 13Regulatory milestoneSAb Biotherapeutics, Inc.SAB-142

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.